Market Expansion Rimsys has recently launched Market Access, an AI-native product to assess market viability and entry requirements, signaling a strategic opportunity to upsell to customers expanding globally and needing efficient regulatory planning.

Regulatory Execution The May 2026 release of the Regulatory Execution engine for MedTech suggests potential for cross-sell to current clients seeking end-to-end regulatory workload automation and faster time-to-market across jurisdictions.

Strategic Partnerships A KPMG alliance indicates a pathway to co-sell or integrate with large professional services networks, opening doors to enterprise deals and referral opportunities with established medtech clients.

Global Growth Funding Recent growth funding and a $2M investment highlight investor confidence and potential for expansion into new regions; leverage funding momentum to pitch scalable regulatory platform deployments to mid-market and global medtech firms.

Regulatory Intelligence Community-driven regulatory intelligence and a focus on regulatory performance reports position Rimsys as a data-enabled authority; propose targeted value propositions around intelligence, change management, and audit-ready regulatory data for regulated product portfolios.